Cite
Aprepitant: an antiemetic drug, contributes to the prevention of acute lung injury with its anti-inflammatory and antioxidant properties
MLA
Tugba Bal Tastan, et al. “Aprepitant: An Antiemetic Drug, Contributes to the Prevention of Acute Lung Injury with Its Anti-Inflammatory and Antioxidant Properties.” Journal of Pharmacy and Pharmacology, vol. 73, June 2021, pp. 1302–09. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....64de3b239942cf60af4a8b9f2336b563&authtype=sso&custid=ns315887.
APA
Tugba Bal Tastan, Rustem Anil Ugan, Duygu Kose, Zekai Halici, Elif Cadirci, Harun Un, & Aysenur Kahramanlar. (2021). Aprepitant: an antiemetic drug, contributes to the prevention of acute lung injury with its anti-inflammatory and antioxidant properties. Journal of Pharmacy and Pharmacology, 73, 1302–1309.
Chicago
Tugba Bal Tastan, Rustem Anil Ugan, Duygu Kose, Zekai Halici, Elif Cadirci, Harun Un, and Aysenur Kahramanlar. 2021. “Aprepitant: An Antiemetic Drug, Contributes to the Prevention of Acute Lung Injury with Its Anti-Inflammatory and Antioxidant Properties.” Journal of Pharmacy and Pharmacology 73 (June): 1302–9. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....64de3b239942cf60af4a8b9f2336b563&authtype=sso&custid=ns315887.